Literature DB >> 20533058

Invited commentary on "Yun HR, Kim HC, Kim SH et al. (2010) Cytokeratin staining for complete remission in rectal cancer after chemoradiation. Int J Colorect Dis.

Paul Hermanek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20533058     DOI： 10.1007/s00384-010-0956-z

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  18 in total

1.  Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision.

Authors:  Krzysztof Bujko; Marek P Nowacki; Anna Nasierowska-Guttmejer; Lucyna Kepka; Barbara Winkler-Spytkowska; Rafal Suwiński; Janusz Oledzki; Grazyna Stryczyńska; Andrzej Wieczorek; Krystyna Serkies; Danuta Rogowska; Piotr Tokar
Journal:  Radiother Oncol       Date:  2005-09       Impact factor: 6.280

2.  Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer.

Authors:  Margherita Gavioli; Gabriele Luppi; Lorena Losi; Federica Bertolini; Mario Santantonio; Anna Maria Falchi; Roberto D'Amico; Pier Franco Conte; Gianni Natalini
Journal:  Dis Colon Rectum       Date:  2005-10       Impact factor: 4.585

3.  The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.

Authors:  Fabio Maria Vecchio; Vincenzo Valentini; Bruce D Minsky; Gilbert D A Padula; Ennapadam S Venkatraman; Mario Balducci; Francesco Miccichè; Riccardo Ricci; Alessio Giuseppe Morganti; Maria Antonietta Gambacorta; Francesca Maurizi; Claudio Coco
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

Review 4.  Modern management of colorectal cancer--a pathologist's view.

Authors:  N J Maughan; P Quirke
Journal:  Scand J Surg       Date:  2003       Impact factor: 2.360

5.  Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

Authors:  Jose G Guillem; David B Chessin; Alfred M Cohen; Jinru Shia; Madhu Mazumdar; Warren Enker; Philip B Paty; Martin R Weiser; David Klimstra; Leonard Saltz; Bruce D Minsky; W Douglas Wong
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

6.  Response to neoadjuvant therapy for rectal cancer: influence on long-term results.

Authors:  S Biondo; M Navarro; J Marti-Rague; E Arriola; D Pares; C Del Rio; M Cambray; V Novell
Journal:  Colorectal Dis       Date:  2005-09       Impact factor: 3.788

7.  Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.

Authors:  A M Mandard; F Dalibard; J C Mandard; J Marnay; M Henry-Amar; J F Petiot; A Roussel; J H Jacob; P Segol; G Samama
Journal:  Cancer       Date:  1994-06-01       Impact factor: 6.860

8.  The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.

Authors:  J Lindebjerg; K-L G Spindler; J Ploen; A Jakobsen
Journal:  Colorectal Dis       Date:  2008-06-20       Impact factor: 3.788

Review 9.  Evidence and research in rectal cancer.

Authors:  Vincenzo Valentini; Regina Beets-Tan; Josep M Borras; Zoran Krivokapić; Jan Willem Leer; Lars Påhlman; Claus Rödel; Hans Joachim Schmoll; Nigel Scott; Cornelius Van de Velde; Christine Verfaillie
Journal:  Radiother Oncol       Date:  2008-06-03       Impact factor: 6.280

10.  A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.

Authors:  D Beddy; J M P Hyland; D C Winter; C Lim; A White; M Moriarty; J Armstrong; D Fennelly; D Gibbons; K Sheahan
Journal:  Ann Surg Oncol       Date:  2008-10-10       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.